Indiana University has established a new spinout, Digital Health Solutions, to commercialise technology that will improve the quality of care of children.

Novo has reinvested in the cancer drug developer as part of a Versant Ventures-led round that increased its overall funding to approximately $108m since 2011.

Touchstone Innovations has co-led the series A round for Apcintex, a spinout of Cambridge University that is working on a treatment for haemophilia.

Cellestia Biotech, an oncology drug spinout of EPFL, has closed its seed funding at $8m after securing a third tranche backed by PPF Group, the owner of biotech company Sotio.

Oncology drug startup Cellestia Biotech has closed its seed funding at $8m after securing a third tranche backed by PPF Group, the owner of biotech company Sotio.

Celgene and Pharmstandard scored exits as part of an initial public offering in which immuno-oncology company Jounce floated above its range.